• PPM-18 Workflows for iNOS and NF-κB Research

  2026-08-17

  PPM-18 provides a practical way to connect NF-κB activation with downstream iNOS expression, nitrite accumulation, and inflammatory cytokine release. This workflow-focused guide shows how to prepare the compound, design macrophage assays, interpret sepsis-relevant endpoints, and troubleshoot common sources of variability.

• Anti Reverse Cap Analog for Synthetic mRNA

  2026-08-16

  Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, gives in vitro transcription workflows a directionally selective Cap 0 structure designed for stronger protein output. Its value is especially clear when repeated, transient expression is needed for cellular reprogramming, mRNA therapeutics research, or other high-expression assays.

• Targeted SPP1 Inhibition in Tumor-Associated Myeloid Cells

  2026-08-15

  The reference study combines a macrophage phenotypic screen with TAM-avid nanodelivery to suppress SPP1 in tumor-associated myeloid cells. Its lead candidate, CANDI460, reduced SPP1 expression in vitro and in vivo and produced tumor remissions in several murine models, while also illustrating the distinction between biomarker association and therapeutically actionable macrophage state.

• Streptavidin-FITC for Biotin Detection Workflows

  2026-08-14

  Streptavidin-FITC converts biotinylated antibodies, probes, and proteins into a measurable green-fluorescence signal across imaging and flow workflows. This guide applies the reagent to the ST3GAL1–Fusobacterium nucleatum colorectal cancer model while emphasizing assay controls, starting conditions, and troubleshooting decisions.

• HLTP1 Targets JNK in Liver Ischemia-Reperfusion

  2026-08-14

  A 2026 World Journal of Gastroenterology study used peptidomics of human liver-transplant samples to identify human liver transplantation peptide 1 (HLTP1), a candidate hepatoprotective peptide. In mouse and AML12-cell models, HLTP1 reduced hepatic ischemia-reperfusion injury and apoptosis, with rescue experiments implicating suppression of Jun N-terminal kinase phosphorylation.

• Live-Dead Cell Staining Kit I: Practical Guide

  2026-08-13

  Learn how Live-Dead Cell Staining Kit I (Calcein AM/PI), SKU K2247, can improve mammalian cell viability and cytotoxicity workflows through complementary viability and membrane-integrity readouts. Five laboratory scenarios cover assay design, protocol optimization, interpretation, and practical vendor selection.

• Magnetic Stimulation, GABRE, and Schizophrenia

  2026-08-13

  This Molecular Psychiatry study identifies the GABAA receptor ε subunit, GABRE, in the left prelimbic cortex as a selective and functionally important mediator of schizophrenia-like behaviors in mice. By combining targeted magnetic stimulation with Gabre loss- and gain-of-function models, the authors connect regional GABRE regulation to synaptic abnormalities and propose a p62/SQSTM1–GABARAP-related mechanism for neuromodulatory action.

• Cyclophosphamide Workflows for Cancer Research

  2026-08-12

  Build reproducible Cyclophosphamide workflows for apoptosis studies, immune modulation, and translational cancer research. This guide connects concentration control, hepatic bioactivation, assay timing, and troubleshooting to practical use cases including lymphoma treatment research and bone marrow transplantation conditioning.

• T7 RNA Transcription for ROS-Ferroptosis Research

  2026-08-12

  A translational roadmap connecting the ROS–ferroptosis–inflammation cycle in intervertebral disc degeneration with fit-for-purpose RNA production, mechanistic validation, and strategic use of the HyperScribe T7 High Yield RNA Synthesis Kit.

• N1-Methylpseudouridine in Cardiac Translation

  2026-08-11

  A mechanism-led perspective on how N1-Methylpseudouridine can support mRNA translation studies inspired by HEY2-dependent cardiac metabolic regulation, with practical validation guidance, competitive context, and clear translational limitations.

• HyperScribe All in One mRNA Synthesis Kit Workflow

  2026-08-11

  Learn how to use an ARCA-capped, polyadenylated mRNA workflow for translation studies, RNAi, and neoantigen vaccine research. This practical guide connects reaction design, quality control, troubleshooting, and the spleen-targeted HCC vaccine findings reported by Lin et al.

• TRIM66 and Monogenic Olfactory Receptor Expression

  2026-08-10

  This reference study identifies TRIM66 as an epigenetic repressor that helps olfactory sensory neurons transition from low-level expression of multiple receptor genes to a stable one-neuron–one-receptor state. Genetic loss of Trim66 disrupts receptor expression, neural activity, and innate olfactory behaviors, linking enhancer repression to sensory function.

• MRT68921: Strategic Control of Autophagy Initiation

  2026-08-09

  MRT68921 provides a mechanistically anchored way to interrogate ULK1/2-dependent autophagy initiation. This thought-leadership guide connects lipid-stress biology, orthogonal pharmacodynamic assays, experimental controls, and translational limitations for researchers planning preclinical autophagy studies.

• 2-NBDG Assay: From Signal to Mechanism

  2026-08-08

  The 2-NBDG Glucose Uptake Assay Kit can connect transporter-dependent glucose accumulation with mechanistic studies of therapy resistance. This guide explains what the fluorescent signal means, how to control interpretation, and how to integrate it with the HNF4A-AS1 ferroptosis model.

• DiscoveryProbe™ Metabolism-related Compound Library

  2026-08-07

  The DiscoveryProbe™ Metabolism-related Compound Library provides a pre-dissolved, quality-controlled set of 493 metabolism-related compounds for organized enzyme, pathway, and cell-based screening. It is intended for in vitro and ex vivo research, not for diagnostic, therapeutic, or clinical use, and individual compound activity must be confirmed in the investigator’s assay system.

8481 records 3/566 page Previous Next 12345 下5页 Last page